Future Drug Treatments for Type 2 Diabetes

Bailey, Clifford J.

doi:10.1002/9781119697473.ch79

Textbook of Diabetes 2024

DOI: 10.1002/9781119697473.ch79

|View full text |Cite

Future Drug Treatments for Type 2 Diabetes

Clifford J. Bailey

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 77 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Diabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg)

Bando,

Okada,

Iwatsuki

et al. 2024

Asp Biomed Clin Case Rep

View full text Add to dashboard Cite

The patient is a 73-year-old male with type 2 diabetes (T2D) and hypertension, treated for years with various oral hypoglycemic agents (OHAs) and an anti-hypertensive agent (AHA). His HbA1c levels were unstable during 2020-2022, during which time he was prescribed linagliptin, voglibose, and metformin. In 2023, his HbA1c increased to 8.4%, and imeglimin (Twymeeg) was initiated. This resulted in an acute reduction of HbA1c to 6.5% over 5 months. A pulse wave velocity (PWV) examination, using a sphygmograph, showed stable values for the cardio-ankle vascular index (CAVI) and ankle-brachial index (ABI) over 4 years. Consequently, this patient has maintained a low level of arteriosclerosis, associated with the effective treatment using imeglimin.

show abstract

Diabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg)

Bando,

Okada,

Iwatsuki

et al. 2024

Asp Biomed Clin Case Rep

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Future Drug Treatments for Type 2 Diabetes

Cited by 1 publication

References 77 publications

Diabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg)

Diabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg)

Contact Info

Product

Resources

About